IL7
Interleukin-7
Also known as: IL-7, IL7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13232
- Gene
- IL7
- Ensembl
- ENSG00000104432
- Chromosome
- 8
- Canonical length
- 177 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
177 residues, UniProt reviewed canonical sequence.
>P13232|IL7
1 MFHVSFRYIF GLPPLILVLL PVASSDCDIE GKDGKQYESV LMVSIDQLLD SMKEIGSNCL
61 NNEFNFFKRH ICDANKEGMF LFRAARKLRQ FLKMNSTGDF DLHLLKVSEG TTILLNCTGQ
121 VKGRKPAALG EAQPTKSLEE NKSLKEQKKL NDLCFLKRLL QEIKTCWNKI LMGTKEHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 8.3 nTPM
Expression across tissuesHPA
Tissue
- skin: 8.3 nTPM
- small intestine: 8.2 nTPM
- lymph node: 8.1 nTPM
- duodenum: 6.3 nTPM
- colon: 4.8 nTPM
- fallopian tube: 4.5 nTPM
Single-cell type
- epicardial cells: 259 nCPM
- late spermatids: 247 nCPM
- lymphatic endothelial cells: 203 nCPM
- fibro-adipogenic progenitors: 191 nCPM
- retinal ganglion cells: 178 nCPM
- cardiomyocytes: 158 nCPM
Immune cell
- memory B-cell: 9.8 nTPM
- naive B-cell: 8.8 nTPM
- T-reg: 7.3 nTPM
- basophil: 5.2 nTPM
- myeloid DC: 2.2 nTPM
- memory CD4 T-cell: 1 nTPM
Brain region
- hypothalamus: 3.1 nTPM
- medulla oblongata: 1.9 nTPM
- thalamus: 1.9 nTPM
- midbrain: 1.4 nTPM
- spinal cord: 1.4 nTPM
- cerebellum: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL7.
Disease | AllUniProt
Conditions IL7 is implicated in, by any mechanism.
- Immunodeficiency 130 with HPV-related verrucosis (IMD130) MIM:618309
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 37 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Epidermodysplasia verruciformis, susceptibility to, 5
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.93
- gnomAD missense Z
- 0.7
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ morphogenesis
- B cell proliferation
- bone resorption
- cell-cell signaling
- cytokine-mediated signaling pathway
- extrinsic apoptotic signaling pathway
- homeostasis of number of cells within a tissue
- humoral immune response
- interleukin-7-mediated signaling pathway
- negative regulation of apoptotic process
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- organ growth
- positive regulation of B cell differentiation
- positive regulation of B cell proliferation
- positive regulation of cell population proliferation
- positive regulation of chemokine production
- positive regulation of cytokine-mediated signaling pathway
- positive regulation of organ growth
- positive regulation of T cell differentiation
- T cell lineage commitment
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interleukin-7/Interleukin-9, conserved site
- Interleukin-7
- Interleukin-7 superfamily
- Interleukin 7
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- CSF2RG
- IL7R
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL7 as an antibody target. Whether an autoantibody or antibody against IL7 could matter depends on whether native IL7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL7 is annotated as secreted, so native IL7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...